PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

17.51 -0.31 (-1.74%)

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about PROCEPT BioRobotics Corporation - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

December 02, 2024

Via Benzinga

PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

November 26, 2024

From PROCEPT BioRobotics

Via GlobeNewswire

The Analyst Landscape: 6 Takes On PROCEPT BioRobotics ↗

November 14, 2024

Via Benzinga

Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio? ↗

November 03, 2024

Top mid-cap stock performers: MDGL (+51.70%), PRCT (+34.20%), GSAT (+33.98%), WGS (+31.17%), NXT (+25.91%), VFC (+25.82%), OMCL (+23.22%).

Via Benzinga

PROCEPT BioRobotics's Earnings Outlook ↗

October 25, 2024

Via Benzinga

What Analysts Are Saying About PROCEPT BioRobotics Stock ↗

October 08, 2024

Via Benzinga

Navigating 6 Analyst Ratings For PROCEPT BioRobotics ↗

September 16, 2024

Via Benzinga

Unveiling 4 Analyst Insights On PROCEPT BioRobotics ↗

August 22, 2024

Via Benzinga

Earnings Scheduled For February 25, 2025 ↗

February 25, 2025

Via Benzinga

PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

February 07, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

How Is The Market Feeling About PROCEPT BioRobotics? ↗

January 24, 2025

Via Benzinga

Spruce Point Sees Trouble Ahead For Procept BioRobotics ↗

January 16, 2025

Spruce Point Capital warns of Procept BioRobotics' overstated market potential and growth claims, citing niche product limitations and valuation risks.

Via Benzinga

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗

December 02, 2024

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

Via Benzinga

5 Analysts Assess PROCEPT BioRobotics: What You Need To Know ↗

December 02, 2024

Via Benzinga

Looking Into PROCEPT BioRobotics's Recent Short Interest ↗

November 14, 2024

Via Benzinga

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

October 29, 2024

From PROCEPT BioRobotics

Via GlobeNewswire

Royal Caribbean Sails Onto The IBD 50: Build Your List Of Stocks To Watch With These Top IBD Screens ↗

October 28, 2024

Royal Caribbean earns its spot on the Big Cap 20 with a best-possible 99 Composite Rating, putting it in the top 1% of all stocks.

Via Investor's Business Daily

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

October 28, 2024

From PROCEPT BioRobotics

Via GlobeNewswire

Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential ↗

October 28, 2024

PROCEPT BioRobotics stock gains as Q3 earnings beat estimates with revenue up 66% YoY, driven by strong system sales and consumable revenue growth.

Via Benzinga

Topics Earnings

PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday ↗

October 28, 2024

Via Benzinga

Procept Biorobotics, A Top 5% Stock, Makes A Bullish Move On Quarterly Beat And Raise ↗

October 28, 2024

The company sells systems that perform aquablation to treat enlarged prostates.

Via Investor's Business Daily

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

October 28, 2024

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

October 09, 2024

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

October 07, 2024

From PROCEPT BioRobotics

Via GlobeNewswire

Jim Cramer Says This Retailer Yields 3%: 'Which Is Quite Good' ↗

September 04, 2024

Jim Cramer discusses PROCEPT BioRobotics, Zoetis, Target and Consolidated Edison. "

Via Benzinga

PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

August 28, 2024

From PROCEPT BioRobotics

Via GlobeNewswire

Lucid, Grifols And Amer Sports Are Among Top 8 Mid Cap Stock Gainers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio? ↗

August 25, 2024

Via Benzinga

Nasdaq Gains 0.5%; TJX Earnings Top Estimates ↗

August 21, 2024

Via Benzinga

Toll Brothers Posts Strong Earnings, Joins Keysight, Coty, TJX And Other Big Stocks Moving Higher On Wednesday ↗

August 21, 2024

Via Benzinga

PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

August 21, 2024

Designed to improve efficiency, enhance surgeon and staff experience and deliver a more accurate and consistent treatment plan for better clinical outcomes

From PROCEPT BioRobotics

Via GlobeNewswire

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.